Last 12 months
Inside the activity.
0 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 5 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 29, 2025 Filed Aug 7, 2025 16:15 UTC |
Shoemaker Stephen HDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 919,761 | $0.00 Strike: $2.92 | $0.00 |
DisclosureSEC source: 0001213900-25-073088 · ownership.xml · derivative · entry 2 Shoemaker Stephen H · CIK 0002048098 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 919,761 Underlying: Common Stock · 919,761 shares Expires 2035-07-29 F2 · price: Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a director of the Issuer. F1 · derivative.exercise_date: The options were granted under the 2025 Supplemental Option Plan of the Issuer. The options vested immediately, but were not exercisable until or unless the closing of the transactions contemplated by the July 29, 2025, Securities Purchase Agreement between the Issuer and the purchasers set forth therein occurred, which closing date was August 4, 2025. Separately, the options are not exercisable until stockholder approval of the 2025 Plan is received. If stockholder approval is not received prior to July 29, 2026, the options will be cancelled. F1 · derivative.expiration_date: The options were granted under the 2025 Supplemental Option Plan of the Issuer. The options vested immediately, but were not exercisable until or unless the closing of the transactions contemplated by the July 29, 2025, Securities Purchase Agreement between the Issuer and the purchasers set forth therein occurred, which closing date was August 4, 2025. Separately, the options are not exercisable until stockholder approval of the 2025 Plan is received. If stockholder approval is not received prior to July 29, 2026, the options will be cancelled. Read SEC document |
| July 27, 2025 Filed Aug 18, 2025 21:27 UTC |
ELRAY RESOURCES, INC.Former 10% Owner
|
OtherCommon Stock Purchase Warrants · Derivative | 3,000,000 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001477932-25-006027 · form4.xml · derivative · entry 6 ELRAY RESOURCES, INC. · CIK 0001402371 · Former 10% Owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,000,000 shares Expires 2031-09-30 F1 · kind: On July 27, 2025, Elray Resources, Inc. exercised Common Stock Purchase Warrants to purchase 3,000,000 shares of the Issuer's common stock at an exercise price of $1.68 per share. Elray Resources, Inc. paid the exercise price on a cashless basis, resulting in the Issuer withholding of 1,680,000 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 1,320,000 shares. Read SEC document |
| July 27, 2025 Filed Aug 18, 2025 21:27 UTC |
ELRAY RESOURCES, INC.Former 10% Owner
|
SaleCommon Stock | 1,680,000 | $3.00 | $5,040,000.00 |
DisclosureSEC source: 0001477932-25-006027 · form4.xml · nonDerivative · entry 2 ELRAY RESOURCES, INC. · CIK 0001402371 · Former 10% Owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,638,000 F1 · kind: On July 27, 2025, Elray Resources, Inc. exercised Common Stock Purchase Warrants to purchase 3,000,000 shares of the Issuer's common stock at an exercise price of $1.68 per share. Elray Resources, Inc. paid the exercise price on a cashless basis, resulting in the Issuer withholding of 1,680,000 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 1,320,000 shares. F2 · balance_after: Includes 1,318,000 shares of Common Stock that are expected to be repurchased by the Issuer following the date of this Form 4 pursuant to the terms of that certain Settlement and Release Agreement dated and effective April 23, 2024, by and between the Issuer, Elray Resources, Inc. and Luxor Capital, LLC, as previously disclosed. Read SEC document |
| July 27, 2025 Filed Aug 18, 2025 21:27 UTC |
ELRAY RESOURCES, INC.Former 10% Owner
|
OtherCommon Stock | 3,000,000 | $1.68 | $5,040,000.00 |
DisclosureSEC source: 0001477932-25-006027 · form4.xml · nonDerivative · entry 1 ELRAY RESOURCES, INC. · CIK 0001402371 · Former 10% Owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,318,000 F2 · balance_after: Includes 1,318,000 shares of Common Stock that are expected to be repurchased by the Issuer following the date of this Form 4 pursuant to the terms of that certain Settlement and Release Agreement dated and effective April 23, 2024, by and between the Issuer, Elray Resources, Inc. and Luxor Capital, LLC, as previously disclosed. Read SEC document |
| July 07, 2025 Filed Jul 14, 2025 18:40 UTC |
Jordan BlairDirector · Chief Executive Officer · 10% owner
|
OtherCommon Stock | 160,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-25-063834 · ownership.xml · nonDerivative · entry 2 Jordan Blair · CIK 0002015193 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · Through Blair Jordan Strategy and Finance Consulting Inc. Disclosed balance after: 327,576 F1 · kind: Transfer to a controlled entity, solely for tax planning purposes only. No change in beneficial ownership. F1 · price: Transfer to a controlled entity, solely for tax planning purposes only. No change in beneficial ownership. F2 · ownership.nature: Mr. Jordan owns and controls Blair Jordan Strategy and Finance Consulting Inc. and as such is deemed to beneficially own the securities held by such entity. Read SEC document |
| July 07, 2025 Filed Jul 14, 2025 18:40 UTC |
Jordan BlairDirector · Chief Executive Officer · 10% owner
|
OtherCommon Stock | 160,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-25-063834 · ownership.xml · nonDerivative · entry 1 Jordan Blair · CIK 0002015193 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: Transfer to a controlled entity, solely for tax planning purposes only. No change in beneficial ownership. F1 · price: Transfer to a controlled entity, solely for tax planning purposes only. No change in beneficial ownership. Read SEC document |
| June 17, 2025 Filed Jun 20, 2025 20:45 UTC |
STEINMAN LAWRENCEDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 110,000 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0001213900-25-056269 · ownership.xml · derivative · entry 2 STEINMAN LAWRENCE · CIK 0001132679 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,000 Underlying: Common Stock · 110,000 shares Expires 2035-06-17 F2 · price: Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a member of the Board of Directors of the Issuer. F3 · derivative.exercise_date: The options vest 1/2 on each of December 17, 2025 and June 17, 2026, subject to the recipient's continued service to the Issuer. Issued under the Issuer's 2025 Option Incentive Plan. The 2025 Option Incentive Plan is subject to stockholder approval and (i) no options can be exercised prior to obtaining stockholder approval for such plan, and (ii) the outstanding options will be cancelled, if stockholder approval is not obtained. Read SEC document |
| June 17, 2025 Filed Jun 20, 2025 20:45 UTC |
STEINMAN LAWRENCEDirector
|
GrantCommon Stock | 48,198 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-056269 · ownership.xml · nonDerivative · entry 1 STEINMAN LAWRENCE · CIK 0001132679 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,732 F1 · shares: Represents restricted stock shares subject to time-based vesting, which vest at the rate of 1/2 of such shares on each of December 17, 2025 and June 17, 2026, subject to the recipient's continued service to the Issuer. Issued under the Issuer's 2022 Equity Compensation Plan. F2 · price: Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a member of the Board of Directors of the Issuer. Read SEC document |
| June 17, 2025 Filed Jun 20, 2025 16:40 UTC |
Van Lent Eric RChief Accounting Officer
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0001213900-25-056258 · ownership.xml · derivative · entry 2 Van Lent Eric R · CIK 0002057653 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2035-06-17 F2 · price: Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as Chief Accounting Officer of the Issuer. F3 · derivative.exercise_date: The options vest 1/2 on each of December 17, 2025 and June 17, 2026, subject to the recipient's continued service to the Issuer. Issued under the Issuer's 2025 Option Incentive Plan. The 2025 Option Incentive Plan is subject to stockholder approval and (i) no options can be exercised prior to obtaining stockholder approval for such plan, and (ii) the outstanding options will be cancelled, if stockholder approval is not obtained. Read SEC document |
| June 17, 2025 Filed Jun 20, 2025 16:40 UTC |
Van Lent Eric RChief Accounting Officer
|
GrantCommon Stock | 8,763 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-056258 · ownership.xml · nonDerivative · entry 1 Van Lent Eric R · CIK 0002057653 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,763 F1 · shares: Represents restricted stock shares subject to time-based vesting, which vest at the rate of 1/2 of such shares on each of December 17, 2025 and June 17, 2026, subject to the recipient's continued service to the Issuer. Issued under the Issuer's 2022 Equity Compensation Plan. F2 · price: Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as Chief Accounting Officer of the Issuer. Read SEC document |
| June 17, 2025 Filed Jun 20, 2025 16:45 UTC |
Shoemaker Stephen HDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 165,000 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0001213900-25-056270 · ownership.xml · derivative · entry 2 Shoemaker Stephen H · CIK 0002048098 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,000 Underlying: Common Stock · 165,000 shares Expires 2035-06-17 F2 · price: Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a member of the Board of Directors of the Issuer. F3 · derivative.exercise_date: The options vest 1/2 on each of December 17, 2025 and June 17, 2026, subject to the recipient's continued service to the Issuer. Issued under the Issuer's 2025 Option Incentive Plan. The 2025 Option Incentive Plan is subject to stockholder approval and (i) no options can be exercised prior to obtaining stockholder approval for such plan, and (ii) the outstanding options will be cancelled, if stockholder approval is not obtained. Read SEC document |
| June 17, 2025 Filed Jun 20, 2025 16:45 UTC |
Shoemaker Stephen HDirector
|
GrantCommon Stock | 72,297 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-056270 · ownership.xml · nonDerivative · entry 1 Shoemaker Stephen H · CIK 0002048098 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,297 F1 · shares: Represents restricted stock shares subject to time-based vesting, which vest at the rate of 1/2 of such shares on each of December 17, 2025 and June 17, 2026, subject to the recipient's continued service to the Issuer. Issued under the Issuer's 2022 Equity Compensation Plan. F2 · price: Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a member of the Board of Directors of the Issuer. Read SEC document |
| June 17, 2025 Filed Jun 20, 2025 16:40 UTC |
Jordan BlairDirector · Chief Executive Officer · 10% owner
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 410,000 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0001213900-25-056259 · ownership.xml · derivative · entry 6 Jordan Blair · CIK 0002015193 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · Through Blair Jordan Strategy and Finance Consulting Inc. Disclosed balance after: 410,000 Underlying: Common Stock · 410,000 shares Expires 2035-06-17 F2 · price: Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as Chief Executive Officer of the Issuer. F10 · derivative.exercise_date: The options vest 1/2 on each of December 17, 2025 and June 17, 2026, subject to the recipient's continued service to the Issuer. Issued under the Issuer's 2025 Option Incentive Plan. The 2025 Option Incentive Plan is subject to stockholder approval and (i) no options can be exercised prior to obtaining stockholder approval for such plan, and (ii) the outstanding options will be cancelled, if stockholder approval is not obtained. F3 · ownership.nature: Mr. Jordan owns and controls Blair Jordan Strategy and Finance Consulting Inc. and as such is deemed to beneficially own the securities held by such entity. Read SEC document |
| June 17, 2025 Filed Jun 20, 2025 16:40 UTC |
Jordan BlairDirector · Chief Executive Officer · 10% owner
|
GrantCommon Stock | 179,646 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-056259 · ownership.xml · nonDerivative · entry 2 Jordan Blair · CIK 0002015193 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · Through Blair Jordan Strategy and Finance Consulting Inc. Disclosed balance after: 179,646 F1 · shares: Represents restricted stock shares subject to time-based vesting, which vest at the rate of 1/2 of such shares on each of December 17, 2025 and June 17, 2026, subject to the recipient's continued service to the Issuer. Issued under the Issuer's 2022 Equity Compensation Plan. F2 · price: Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as Chief Executive Officer of the Issuer. F3 · ownership.nature: Mr. Jordan owns and controls Blair Jordan Strategy and Finance Consulting Inc. and as such is deemed to beneficially own the securities held by such entity. Read SEC document |
| June 17, 2025 Filed Jun 20, 2025 20:40 UTC |
Smith Ryan LewisDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 255,000 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0001213900-25-056257 · ownership.xml · derivative · entry 2 Smith Ryan Lewis · CIK 0001619129 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 255,000 Underlying: Common Stock · 255,000 shares Expires 2035-06-17 F2 · price: Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a member of the Board of Directors of the Issuer. F3 · derivative.exercise_date: The options vest 1/2 on each of December 17, 2025 and June 17, 2026, subject to the recipient's continued service to the Issuer. Issued under the Issuer's 2025 Option Incentive Plan. The 2025 Option Incentive Plan is subject to stockholder approval and (i) no options can be exercised prior to obtaining stockholder approval for such plan, and (ii) the outstanding options will be cancelled, if stockholder approval is not obtained. Read SEC document |
| June 17, 2025 Filed Jun 20, 2025 20:40 UTC |
Smith Ryan LewisDirector
|
GrantCommon Stock | 109,541 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-056257 · ownership.xml · nonDerivative · entry 1 Smith Ryan Lewis · CIK 0001619129 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 174,541 F1 · shares: Represents restricted stock shares subject to time-based vesting, which vest at the rate of 1/2 of such shares on each of December 17, 2025 and June 17, 2026, subject to the recipient's continued service to the Issuer. Issued under the Issuer's 2022 Equity Compensation Plan. F2 · price: Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a member of the Board of Directors of the Issuer. Read SEC document |
| June 17, 2025 Filed Jun 30, 2025 21:34 UTC Amendment |
STEINMAN LAWRENCEDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 110,000 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0001213900-25-059798 · ownership.xml · derivative · entry 2 STEINMAN LAWRENCE · CIK 0001132679 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,000 Underlying: Common Stock · 110,000 shares Expires 2035-06-17 F2 · price: Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a member of the Board of Directors of the Issuer. F3 · derivative.exercise_date: The options vest 1/2 on each of December 17, 2025 and June 17, 2026, subject to the recipient's continued service to the Issuer. Issued under the Issuer's 2025 Option Incentive Plan. The 2025 Option Incentive Plan is subject to stockholder approval and (i) no options can be exercised prior to obtaining stockholder approval for such plan, and (ii) the outstanding options will be cancelled, if stockholder approval is not obtained. Read SEC document |
| June 17, 2025 Filed Jun 30, 2025 21:34 UTC Amendment |
STEINMAN LAWRENCEDirector
|
GrantCommon Stock | 44,959 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-059798 · ownership.xml · nonDerivative · entry 1 STEINMAN LAWRENCE · CIK 0001132679 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,493 F1 · shares: Represents restricted stock shares subject to time-based vesting, which vest at the rate of 1/2 of such shares on each of December 17, 2025 and June 17, 2026, subject to the recipient's continued service to the Issuer. Issued under the Issuer's 2022 Equity Compensation Plan (the "Equity Plan"). F2 · price: Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a member of the Board of Directors of the Issuer. Read SEC document |
| June 17, 2025 Filed Jun 30, 2025 17:31 UTC Amendment |
Van Lent Eric RChief Accounting Officer
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0001213900-25-059791 · ownership.xml · derivative · entry 2 Van Lent Eric R · CIK 0002057653 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2035-06-17 F2 · price: Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as Chief Accounting Officer of the Issuer. F3 · derivative.exercise_date: The options vest 1/2 on each of December 17, 2025 and June 17, 2026, subject to the recipient's continued service to the Issuer. Issued under the Issuer's 2025 Option Incentive Plan. The 2025 Option Incentive Plan is subject to stockholder approval and (i) no options can be exercised prior to obtaining stockholder approval for such plan, and (ii) the outstanding options will be cancelled, if stockholder approval is not obtained. Read SEC document |
| June 17, 2025 Filed Jun 30, 2025 17:31 UTC Amendment |
Van Lent Eric RChief Accounting Officer
|
GrantCommon Stock | 8,174 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-059791 · ownership.xml · nonDerivative · entry 1 Van Lent Eric R · CIK 0002057653 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,174 F1 · shares: Represents restricted stock shares subject to time-based vesting, which vest at the rate of 1/2 of such shares on each of December 17, 2025 and June 17, 2026, subject to the recipient's continued service to the Issuer. Issued under the Issuer's 2022 Equity Compensation Plan (the "Equity Plan"). F2 · price: Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as Chief Accounting Officer of the Issuer. Read SEC document |
| June 17, 2025 Filed Jun 30, 2025 17:33 UTC Amendment |
Shoemaker Stephen HDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 165,000 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0001213900-25-059795 · ownership.xml · derivative · entry 2 Shoemaker Stephen H · CIK 0002048098 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,000 Underlying: Common Stock · 165,000 shares Expires 2035-06-17 F2 · price: Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a member of the Board of Directors of the Issuer. F3 · derivative.exercise_date: The options vest 1/2 on each of December 17, 2025 and June 17, 2026, subject to the recipient's continued service to the Issuer. Issued under the Issuer's 2025 Option Incentive Plan. The 2025 Option Incentive Plan is subject to stockholder approval and (i) no options can be exercised prior to obtaining stockholder approval for such plan, and (ii) the outstanding options will be cancelled, if stockholder approval is not obtained. Read SEC document |
| June 17, 2025 Filed Jun 30, 2025 17:33 UTC Amendment |
Shoemaker Stephen HDirector
|
GrantCommon Stock | 67,439 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-059795 · ownership.xml · nonDerivative · entry 1 Shoemaker Stephen H · CIK 0002048098 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,439 F1 · shares: Represents restricted stock shares subject to time-based vesting, which vest at the rate of 1/2 of such shares on each of December 17, 2025 and June 17, 2026, subject to the recipient's continued service to the Issuer. Issued under the Issuer's 2022 Equity Compensation Plan (the "Equity Plan"). F2 · price: Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a member of the Board of Directors of the Issuer. Read SEC document |
| June 17, 2025 Filed Jun 30, 2025 17:32 UTC Amendment |
Jordan BlairDirector · Chief Executive Officer · 10% owner
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 410,000 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0001213900-25-059794 · ownership.xml · derivative · entry 6 Jordan Blair · CIK 0002015193 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · Through Blair Jordan Strategy and Finance Consulting Inc. Disclosed balance after: 410,000 Underlying: Common Stock · 410,000 shares Expires 2035-06-17 F2 · price: Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as Chief Executive Officer of the Issuer. F10 · derivative.exercise_date: The options vest 1/2 on each of December 17, 2025 and June 17, 2026, subject to the recipient's continued service to the Issuer. Issued under the Issuer's 2025 Option Incentive Plan. The 2025 Option Incentive Plan is subject to stockholder approval and (i) no options can be exercised prior to obtaining stockholder approval for such plan, and (ii) the outstanding options will be cancelled, if stockholder approval is not obtained. F3 · ownership.nature: Mr. Jordan owns and controls Blair Jordan Strategy and Finance Consulting Inc. and as such is deemed to beneficially own the securities held by such entity. Read SEC document |
| June 17, 2025 Filed Jun 30, 2025 17:32 UTC Amendment |
Jordan BlairDirector · Chief Executive Officer · 10% owner
|
GrantCommon Stock | 167,576 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-059794 · ownership.xml · nonDerivative · entry 2 Jordan Blair · CIK 0002015193 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · Through Blair Jordan Strategy and Finance Consulting Inc. Disclosed balance after: 167,576 F1 · shares: Represents restricted stock shares subject to time-based vesting, which vest at the rate of 1/2 of such shares on each of December 17, 2025 and June 17, 2026, subject to the recipient's continued service to the Issuer. Issued under the Issuer's 2022 Equity Compensation Plan (the "Equity Plan"). F2 · price: Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as Chief Executive Officer of the Issuer. F3 · ownership.nature: Mr. Jordan owns and controls Blair Jordan Strategy and Finance Consulting Inc. and as such is deemed to beneficially own the securities held by such entity. Read SEC document |
| June 17, 2025 Filed Jun 30, 2025 21:34 UTC Amendment |
Smith Ryan LewisDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 255,000 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0001213900-25-059797 · ownership.xml · derivative · entry 2 Smith Ryan Lewis · CIK 0001619129 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 255,000 Underlying: Common Stock · 255,000 shares Expires 2035-06-17 F2 · price: Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a member of the Board of Directors of the Issuer. F3 · derivative.exercise_date: The options vest 1/2 on each of December 17, 2025 and June 17, 2026, subject to the recipient's continued service to the Issuer. Issued under the Issuer's 2025 Option Incentive Plan. The 2025 Option Incentive Plan is subject to stockholder approval and (i) no options can be exercised prior to obtaining stockholder approval for such plan, and (ii) the outstanding options will be cancelled, if stockholder approval is not obtained. Read SEC document |
| June 17, 2025 Filed Jun 30, 2025 21:34 UTC Amendment |
Smith Ryan LewisDirector
|
GrantCommon Stock | 102,181 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-059797 · ownership.xml · nonDerivative · entry 1 Smith Ryan Lewis · CIK 0001619129 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 167,181 F1 · shares: Represents restricted stock shares subject to time-based vesting, which vest at the rate of 1/2 of such shares on each of December 17, 2025 and June 17, 2026, subject to the recipient's continued service to the Issuer. Issued under the Issuer's 2022 Equity Compensation Plan (the "Equity Plan"). F2 · price: Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a member of the Board of Directors of the Issuer. Read SEC document |
| April 28, 2025 Filed Apr 30, 2025 17:57 UTC |
Jordan BlairDirector · Chief Executive Officer · 10% owner
|
OtherCommon Stock | 1,318,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-037801 · ownership.xml · nonDerivative · entry 4 Jordan Blair · CIK 0002015193 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,318,000 F5 · kind: On April 28, 2025, the Issuer, the Reporting Person and Elray Resources, Inc. ("Elray") entered into a Voting Agreement, whereby Elray agreed to vote a total of 1,318,000 shares of the Issuer's common stock, as recommended by the Board of Directors of the Issuer, at any meeting of stockholders or via any written consent of stockholders, which may occur prior to April 28, 2026. In order to enforce the terms of the Voting Agreement, Elray provided the Reporting Person (or his assigns), solely for the benefit of the Issuer, an irrevocable voting proxy to vote the 1,318,000 shares pursuant to the guidelines set forth above at any meeting of stockholders or via any written consent of stockholders. F6 · kind: As a result of the irrevocable voting proxy, Mr. Jordan may be deemed to beneficially own the 1,318,000 shares of common stock of the Issuer held by Elray. Except for the limited right to vote such shares pursuant to the Voting Agreement, Mr. Jordan has no dispositive control over the shares, nor any pecuniary interest therein. F5 · acquired: On April 28, 2025, the Issuer, the Reporting Person and Elray Resources, Inc. ("Elray") entered into a Voting Agreement, whereby Elray agreed to vote a total of 1,318,000 shares of the Issuer's common stock, as recommended by the Board of Directors of the Issuer, at any meeting of stockholders or via any written consent of stockholders, which may occur prior to April 28, 2026. In order to enforce the terms of the Voting Agreement, Elray provided the Reporting Person (or his assigns), solely for the benefit of the Issuer, an irrevocable voting proxy to vote the 1,318,000 shares pursuant to the guidelines set forth above at any meeting of stockholders or via any written consent of stockholders. F6 · acquired: As a result of the irrevocable voting proxy, Mr. Jordan may be deemed to beneficially own the 1,318,000 shares of common stock of the Issuer held by Elray. Except for the limited right to vote such shares pursuant to the Voting Agreement, Mr. Jordan has no dispositive control over the shares, nor any pecuniary interest therein. F5 · ownership.nature: On April 28, 2025, the Issuer, the Reporting Person and Elray Resources, Inc. ("Elray") entered into a Voting Agreement, whereby Elray agreed to vote a total of 1,318,000 shares of the Issuer's common stock, as recommended by the Board of Directors of the Issuer, at any meeting of stockholders or via any written consent of stockholders, which may occur prior to April 28, 2026. In order to enforce the terms of the Voting Agreement, Elray provided the Reporting Person (or his assigns), solely for the benefit of the Issuer, an irrevocable voting proxy to vote the 1,318,000 shares pursuant to the guidelines set forth above at any meeting of stockholders or via any written consent of stockholders. F6 · ownership.nature: As a result of the irrevocable voting proxy, Mr. Jordan may be deemed to beneficially own the 1,318,000 shares of common stock of the Issuer held by Elray. Except for the limited right to vote such shares pursuant to the Voting Agreement, Mr. Jordan has no dispositive control over the shares, nor any pecuniary interest therein. Read SEC document |
| March 27, 2025 Filed Apr 11, 2025 22:05 UTC |
ELRAY RESOURCES, INC.10% owner
|
ConversionSeries B Convertible Preferred Stock · Derivative | 1,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-031196 · ownership.xml · derivative · entry 2 ELRAY RESOURCES, INC. · CIK 0001402371 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,318,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each of the 1,000,000 shares of Series B Convertible Preferred Stock was convertible into 1.318 shares of common stock. F3 · derivative.expiration_date: The Series B Convertible Preferred Stock has no expiration date. Read SEC document |
| March 27, 2025 Filed Apr 11, 2025 22:05 UTC |
ELRAY RESOURCES, INC.10% owner
|
ConversionCommon Stock | 1,318,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-25-031196 · ownership.xml · nonDerivative · entry 1 ELRAY RESOURCES, INC. · CIK 0001402371 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,318,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On March 27, 2025, Elray Resources, Inc., converted all 1,000,000 outstanding shares of Series B Convertible Preferred Stock of the Issuer which it then held into 1,318,000 shares of common stock (1.318 shares of common stock for each share of Series B Convertible Preferred Stock converted), in accordance with the terms of such preferred stock and the optional conversion right set forth therein. Read SEC document |
| February 21, 2025 Filed Apr 2, 2025 16:59 UTC |
Jordan BlairDirector · Chief Executive Officer
|
OtherCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-028119 · ownership.xml · nonDerivative · entry 3 Jordan Blair · CIK 0002015193 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 200,000 F3 · kind: On February 21, 2025, the Issuer, the Reporting Person and Dr. Marlene Krauss, entered into a Voting Agreement, whereby Dr. Krauss agreed to vote a total of 200,000 shares of the Issuer's common stock, as recommended by the Board of Directors of the Issuer, at any meeting of stockholders or via any written consent of stockholders, which may occur prior to August 21, 2025. In order to enforce the terms of the Voting Agreement, Dr. Krauss provided the Reporting Person (or his assigns), solely for the benefit of the Issuer, an irrevocable voting proxy to vote the 200,000 shares pursuant to the guidelines set forth above at any meeting of stockholders or via any written consent of stockholders. F4 · kind: As a result of the irrevocable voting proxy, Mr. Jordan may be deemed to beneficially own the 200,000 shares of common stock of the Issuer held by Dr. Krauss. Except for the limited right to vote such shares pursuant to the Voting Agreement, Mr. Jordan has no dispositive control over the shares, nor any pecuniary interest therein. F3 · acquired: On February 21, 2025, the Issuer, the Reporting Person and Dr. Marlene Krauss, entered into a Voting Agreement, whereby Dr. Krauss agreed to vote a total of 200,000 shares of the Issuer's common stock, as recommended by the Board of Directors of the Issuer, at any meeting of stockholders or via any written consent of stockholders, which may occur prior to August 21, 2025. In order to enforce the terms of the Voting Agreement, Dr. Krauss provided the Reporting Person (or his assigns), solely for the benefit of the Issuer, an irrevocable voting proxy to vote the 200,000 shares pursuant to the guidelines set forth above at any meeting of stockholders or via any written consent of stockholders. F4 · acquired: As a result of the irrevocable voting proxy, Mr. Jordan may be deemed to beneficially own the 200,000 shares of common stock of the Issuer held by Dr. Krauss. Except for the limited right to vote such shares pursuant to the Voting Agreement, Mr. Jordan has no dispositive control over the shares, nor any pecuniary interest therein. F3 · ownership.nature: On February 21, 2025, the Issuer, the Reporting Person and Dr. Marlene Krauss, entered into a Voting Agreement, whereby Dr. Krauss agreed to vote a total of 200,000 shares of the Issuer's common stock, as recommended by the Board of Directors of the Issuer, at any meeting of stockholders or via any written consent of stockholders, which may occur prior to August 21, 2025. In order to enforce the terms of the Voting Agreement, Dr. Krauss provided the Reporting Person (or his assigns), solely for the benefit of the Issuer, an irrevocable voting proxy to vote the 200,000 shares pursuant to the guidelines set forth above at any meeting of stockholders or via any written consent of stockholders. F4 · ownership.nature: As a result of the irrevocable voting proxy, Mr. Jordan may be deemed to beneficially own the 200,000 shares of common stock of the Issuer held by Dr. Krauss. Except for the limited right to vote such shares pursuant to the Voting Agreement, Mr. Jordan has no dispositive control over the shares, nor any pecuniary interest therein. Read SEC document |
| February 20, 2025 Filed Feb 21, 2025 23:24 UTC |
STEINMAN LAWRENCEDirector
|
GrantCommon Stock | 65,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-016193 · ownership.xml · nonDerivative · entry 1 STEINMAN LAWRENCE · CIK 0001132679 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,534 F1 · shares: Represents restricted stock shares subject to time-based vesting, which vest at the rate of 1/2 of such shares on each of July 1, 2025 and December 31, 2025, subject to the recipient's continued service to the Issuer. Exempt pursuant to Rule 16b-3. F2 · price: Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a member of the Board of Directors of the Issuer. Issued under the Issuer's 2022 Equity Compensation Plan. Read SEC document |
| February 20, 2025 Filed Feb 21, 2025 18:27 UTC |
Goodman Jay LawrenceDirector
|
GrantCommon Stock | 65,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-016197 · ownership.xml · nonDerivative · entry 1 Goodman Jay Lawrence · CIK 0002042496 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,000 F1 · shares: Represents restricted stock shares subject to time-based vesting, which vest at the rate of 1/2 of such shares on each of July 1, 2025 and December 31, 2025, subject to the recipient's continued service to the Issuer. Exempt pursuant to Rule 16b-3. F2 · price: Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a member of the Board of Directors of the Issuer. Issued under the Issuer's 2022 Equity Compensation Plan. Read SEC document |
| February 20, 2025 Filed Feb 21, 2025 18:26 UTC |
Jordan BlairDirector · Chief Executive Officer
|
GrantCommon Stock | 160,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-016195 · ownership.xml · nonDerivative · entry 2 Jordan Blair · CIK 0002015193 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,000 F3 · shares: Represents restricted stock shares subject to time-based vesting, which vest at the rate of 1/2 of such shares on each of January 1, 2026 and December 31, 2026, subject to the recipient's continued service to the Issuer. Exempt pursuant to Rule 16b-3. F4 · price: Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as an officer of the Issuer. Issued under the Issuer's 2022 Equity Compensation Plan. Read SEC document |
| February 20, 2025 Filed Feb 21, 2025 23:16 UTC |
Smith Ryan LewisDirector
|
GrantCommon Stock | 65,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-016189 · ownership.xml · nonDerivative · entry 1 Smith Ryan Lewis · CIK 0001619129 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,000 F1 · shares: Represents restricted stock shares subject to time-based vesting, which vest at the rate of 1/2 of such shares on each of July 1, 2025 and December 31, 2025, subject to the recipient's continued service to the Issuer. Exempt pursuant to Rule 16b-3. F2 · price: Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a member of the Board of Directors of the Issuer. Issued under the Issuer's 2022 Equity Compensation Plan. Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 16:15 UTC |
Shoemaker Stephen HDirector
|
GrantCommon Stock | 65,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-016627 · ownership.xml · nonDerivative · entry 1 Shoemaker Stephen H · CIK 0002048098 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,000 F1 · shares: Represents restricted stock shares subject to time-based vesting, which vest at the rate of 1/2 of such shares on each of July 1, 2025 and December 31, 2025, subject to the recipient's continued service to the Issuer. Exempt pursuant to Rule 16b-3. F2 · price: Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a member of the Board of Directors of the Issuer. Issued under the Issuer's 2022 Equity Compensation Plan. Read SEC document |
| February 05, 2025 Filed Feb 7, 2025 16:55 UTC |
Jordan BlairDirector · Chief Executive Officer
|
OtherCommon Stock | 43,166 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-011372 · ownership.xml · nonDerivative · entry 1 Jordan Blair · CIK 0002015193 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 43,166 F1 · kind: On February 5, 2025, the Issuer, the Reporting Person and Dr. James Woody, entered into a Voting Agreement, whereby Dr. Woody agreed to vote a total of 43,166 shares of the Issuer's common stock, as recommended by the Board of Directors of the Issuer, at any meeting of stockholders or via any written consent of stockholders, which may occur prior to February 5, 2026, the date after August 5, 2025, that Dr. Woody has sold all of the shares or the date that the Issuer terminates the Voting Agreement. In order to enforce the terms of the Voting Agreement, Dr. Woody provided the Reporting Person (or his assigns), solely for the benefit of the Issuer, an irrevocable voting proxy to vote the 43,166 shares pursuant to the guidelines set forth above at any meeting of stockholders or via any written consent of stockholders. F2 · kind: As a result of the irrevocable voting proxy, Mr. Jordan may be deemed to beneficially own the 43,166 shares of common stock of the Issuer held by Dr. Woody. Except for the limited right to vote such shares pursuant to the Voting Agreement, Mr. Jordan has no dispositive control over the shares, nor any pecuniary interest therein. F1 · acquired: On February 5, 2025, the Issuer, the Reporting Person and Dr. James Woody, entered into a Voting Agreement, whereby Dr. Woody agreed to vote a total of 43,166 shares of the Issuer's common stock, as recommended by the Board of Directors of the Issuer, at any meeting of stockholders or via any written consent of stockholders, which may occur prior to February 5, 2026, the date after August 5, 2025, that Dr. Woody has sold all of the shares or the date that the Issuer terminates the Voting Agreement. In order to enforce the terms of the Voting Agreement, Dr. Woody provided the Reporting Person (or his assigns), solely for the benefit of the Issuer, an irrevocable voting proxy to vote the 43,166 shares pursuant to the guidelines set forth above at any meeting of stockholders or via any written consent of stockholders. F2 · acquired: As a result of the irrevocable voting proxy, Mr. Jordan may be deemed to beneficially own the 43,166 shares of common stock of the Issuer held by Dr. Woody. Except for the limited right to vote such shares pursuant to the Voting Agreement, Mr. Jordan has no dispositive control over the shares, nor any pecuniary interest therein. F1 · ownership.nature: On February 5, 2025, the Issuer, the Reporting Person and Dr. James Woody, entered into a Voting Agreement, whereby Dr. Woody agreed to vote a total of 43,166 shares of the Issuer's common stock, as recommended by the Board of Directors of the Issuer, at any meeting of stockholders or via any written consent of stockholders, which may occur prior to February 5, 2026, the date after August 5, 2025, that Dr. Woody has sold all of the shares or the date that the Issuer terminates the Voting Agreement. In order to enforce the terms of the Voting Agreement, Dr. Woody provided the Reporting Person (or his assigns), solely for the benefit of the Issuer, an irrevocable voting proxy to vote the 43,166 shares pursuant to the guidelines set forth above at any meeting of stockholders or via any written consent of stockholders. F2 · ownership.nature: As a result of the irrevocable voting proxy, Mr. Jordan may be deemed to beneficially own the 43,166 shares of common stock of the Issuer held by Dr. Woody. Except for the limited right to vote such shares pursuant to the Voting Agreement, Mr. Jordan has no dispositive control over the shares, nor any pecuniary interest therein. Read SEC document |
| December 28, 2023 Filed Dec 28, 2023 23:42 UTC |
Feldmann MarcDirector
|
GrantCommon Stock | 135,377 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-23-099335 · ownership.xml · nonDerivative · entry 1 Feldmann Marc · CIK 0001832327 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,874 F1 · kind: Granted to the Reporting Person pursuant to the Issuer's equity compensation plans in consideration for services rendered. Exempt from Section 16(b) of the Securities Exchange Act of 1934 under Rule 16b-3. Read SEC document |
| December 15, 2023 Filed Dec 18, 2023 21:15 UTC |
Feldmann MarcDirector
|
SaleCommon Stock | 25,000 | $0.19 | $4,700.00 |
DisclosureSEC source: 0001213900-23-096503 · ownership.xml · nonDerivative · entry 1 Feldmann Marc · CIK 0001832327 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,497 F1 · kind: Effective on December 15, 2023, Prof. Sir Marc Feldmann, the Co-Executive Chairman of the Issuer, sold 25,000 shares of common stock of the Issuer to Dr. James N. Woody, the Chief Executive Officer of the Issuer, in a private transaction, for $4,720 or $0.188 per share, the closing sales price of the Issuer's common stock on such effective date. Read SEC document |
| December 15, 2023 Filed Dec 18, 2023 21:15 UTC |
Woody James N.Director · Chief Executive Officer
|
PurchaseCommon Stock | 25,000 | $0.19 | $4,700.00 |
DisclosureSEC source: 0001213900-23-096502 · ownership.xml · nonDerivative · entry 1 Woody James N. · CIK 0001553355 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,888 F1 · kind: Effective on December 15, 2023, Dr. James N. Woody, the Chief Executive Officer of the Issuer, purchased 25,000 shares of common stock of the Issuer from Prof. Sir Marc Feldmann, the Co-Executive Chairman of the Issuer, in a private transaction, for $4,720 or $0.188 per share, the closing sales price of the Issuer's common stock on such effective date. Read SEC document |
| September 04, 2023 Filed Sep 6, 2023 22:55 UTC |
STEINMAN LAWRENCEDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $0.67 | $0.00 |
DisclosureSEC source: 0001213900-23-074493 · ownership.xml · derivative · entry 2 STEINMAN LAWRENCE · CIK 0001132679 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2033-09-04 F1 · kind: Granted in consideration for services rendered and to be rendered as a member of the Board of Directors for the quarter ended June 30, 2023. Granted under the registrant's First Amended and Restated 2022 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3. F1 · price: Granted in consideration for services rendered and to be rendered as a member of the Board of Directors for the quarter ended June 30, 2023. Granted under the registrant's First Amended and Restated 2022 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3. F2 · derivative.exercise_date: The options vest at the rate of 1/12th of such options ratably on a monthly basis over the following 12 months on the last day of each calendar month (beginning September 30, 2023), subject to the Reporting Person's continued service to the Company on such vesting dates. Read SEC document |
| September 04, 2023 Filed Sep 6, 2023 22:53 UTC |
Gold Lawrence MarshallDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $0.67 | $0.00 |
DisclosureSEC source: 0001213900-23-074490 · ownership.xml · derivative · entry 2 Gold Lawrence Marshall · CIK 0001355868 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2033-09-04 F2 · kind: Granted in consideration for services rendered and to be rendered as a member of the Board of Directors. Granted under the registrant's Amended and Restated 2022 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3. F2 · price: Granted in consideration for services rendered and to be rendered as a member of the Board of Directors. Granted under the registrant's Amended and Restated 2022 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3. F3 · derivative.exercise_date: The options vest at the rate of 1/12th of such options ratably on a monthly basis over the following 12 months on the last day of each calendar month (beginning September 30, 2023), subject to the Reporting Person's continued service to the Company on such vesting dates. Read SEC document |
| September 04, 2023 Filed Sep 6, 2023 22:53 UTC |
Gold Lawrence MarshallDirector
|
GrantCommon Stock | 21,455 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-23-074490 · ownership.xml · nonDerivative · entry 1 Gold Lawrence Marshall · CIK 0001355868 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,745 F1 · kind: Issued in consideration for serving on the Board of Directors, as a Member of the Audit and Compensation Committee of the Board of Directors, and as Chairman of the Nominating and Corporate Governance Committee of the Board of Directors, for the quarter ended June 30, 2023. Granted under the registrant's Amended and Restated 2022 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3. F1 · price: Issued in consideration for serving on the Board of Directors, as a Member of the Audit and Compensation Committee of the Board of Directors, and as Chairman of the Nominating and Corporate Governance Committee of the Board of Directors, for the quarter ended June 30, 2023. Granted under the registrant's Amended and Restated 2022 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3. Read SEC document |
| September 04, 2023 Filed Sep 6, 2023 22:30 UTC |
Pamir OzanCFO
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $0.67 | $0.00 |
DisclosureSEC source: 0001213900-23-074485 · ownership.xml · derivative · entry 2 Pamir Ozan · CIK 0001834681 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2033-09-04 F1 · kind: The Stock Options were granted to the Reporting Person pursuant to the Issuer's First Amended and Restated 2022 Omnibus Incentive Plan in consideration for services to be rendered as Chief Financial Officer. Exempt from Section 16(b) pursuant to Rule 16b-3. F2 · derivative.exercise_date: The options vest at the rate of 1/12th of such options ratably on a monthly basis over the following 12 months on the last day of each calendar month (beginning September 30, 2023), subject to the Reporting Person's continued service to the Company on such vesting dates. Read SEC document |
| September 04, 2023 Filed Sep 6, 2023 22:28 UTC |
McGovern Jr. Donald A.Director
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 44,776 | $0.00 Strike: $0.67 | $0.00 |
DisclosureSEC source: 0001213900-23-074482 · ownership.xml · derivative · entry 3 McGovern Jr. Donald A. · CIK 0001706276 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,776 Underlying: Common Stock · 44,776 shares Expires 2033-09-04 F4 · kind: Granted in consideration for serving as Lead Director of the Company during 2023. Granted under the registrant's First Amended and Restated 2022 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3. F4 · price: Granted in consideration for serving as Lead Director of the Company during 2023. Granted under the registrant's First Amended and Restated 2022 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3. Read SEC document |
| September 04, 2023 Filed Sep 6, 2023 22:28 UTC |
McGovern Jr. Donald A.Director
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $0.67 | $0.00 |
DisclosureSEC source: 0001213900-23-074482 · ownership.xml · derivative · entry 2 McGovern Jr. Donald A. · CIK 0001706276 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2033-09-04 F2 · kind: Granted in consideration for services rendered and to be rendered as a member of the Board of Directors. Granted under the registrant's First Amended and Restated 2022 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3. F2 · price: Granted in consideration for services rendered and to be rendered as a member of the Board of Directors. Granted under the registrant's First Amended and Restated 2022 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3. F3 · derivative.exercise_date: The options vest at the rate of 1/12th of such options ratably on a monthly basis over the following 12 months on the last day of each calendar month (beginning September 30, 2023), subject to the Reporting Person's continued service to the Company on such vesting dates. Read SEC document |
| September 04, 2023 Filed Sep 6, 2023 22:28 UTC |
McGovern Jr. Donald A.Director
|
GrantCommon Stock | 25,186 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-23-074482 · ownership.xml · nonDerivative · entry 1 McGovern Jr. Donald A. · CIK 0001706276 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,285 F1 · kind: Issued in consideration for serving on the Board of Directors, as Lead Director, Chairman of the Audit Committee, and as a Member of the Compensation Committee and of the Risk, Safety and Regulatory Committee of the Board of Directors, for the quarter ended June 30, 2023. Granted under the registrant's First Amended and Restated 2022 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3. F1 · price: Issued in consideration for serving on the Board of Directors, as Lead Director, Chairman of the Audit Committee, and as a Member of the Compensation Committee and of the Risk, Safety and Regulatory Committee of the Board of Directors, for the quarter ended June 30, 2023. Granted under the registrant's First Amended and Restated 2022 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3. Read SEC document |
| September 04, 2023 Filed Sep 6, 2023 22:24 UTC |
Marrone Pamela GDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $0.67 | $0.00 |
DisclosureSEC source: 0001213900-23-074480 · ownership.xml · derivative · entry 2 Marrone Pamela G · CIK 0001582885 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2033-09-04 F2 · kind: Granted in consideration for services rendered and to be rendered as a member of the Board of Directors. Granted under the registrant's Amended and Restated 2022 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3. F2 · price: Granted in consideration for services rendered and to be rendered as a member of the Board of Directors. Granted under the registrant's Amended and Restated 2022 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3. F3 · derivative.exercise_date: The options vest at the rate of 1/12th of such options ratably on a monthly basis over the following 12 months on the last day of each calendar month (beginning September 30, 2023), subject to the Reporting Person's continued service to the Company on such vesting dates. Read SEC document |
| September 04, 2023 Filed Sep 6, 2023 22:24 UTC |
Marrone Pamela GDirector
|
GrantCommon Stock | 22,388 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-23-074480 · ownership.xml · nonDerivative · entry 1 Marrone Pamela G · CIK 0001582885 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,857.019 F1 · kind: Issued in consideration for serving on the Board of Directors and as a Member of the Compensation and Risk, Safety and Regulatory Committees of the Board of Directors, for the quarter ended June 30, 2023. Granted under the registrant's First Amended and Restated 2022 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3. F1 · price: Issued in consideration for serving on the Board of Directors and as a Member of the Compensation and Risk, Safety and Regulatory Committees of the Board of Directors, for the quarter ended June 30, 2023. Granted under the registrant's First Amended and Restated 2022 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3. Read SEC document |
| September 04, 2023 Filed Sep 8, 2023 20:00 UTC |
Feldmann MarcDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $0.67 | $0.00 |
DisclosureSEC source: 0001213900-23-075380 · ownership.xml · derivative · entry 2 Feldmann Marc · CIK 0001832327 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2033-09-04 F1 · kind: Granted in consideration for services rendered and to be rendered as a member of the Board of Directors for the quarter ended June 30, 2023. Granted under the registrant's First Amended and Restated 2022 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3. F1 · price: Granted in consideration for services rendered and to be rendered as a member of the Board of Directors for the quarter ended June 30, 2023. Granted under the registrant's First Amended and Restated 2022 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3. F2 · derivative.exercise_date: The options vest at the rate of 1/12th of such options ratably on a monthly basis over the following 12 months on the last day of each calendar month (beginning September 30, 2023), subject to the Reporting Person's continued service to the Company on such vesting dates. Read SEC document |
| September 04, 2023 Filed Sep 8, 2023 20:00 UTC |
RAY RUSSELL TDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $0.67 | $0.00 |
DisclosureSEC source: 0001213900-23-075377 · ownership.xml · derivative · entry 2 RAY RUSSELL T · CIK 0001225960 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2033-09-04 F2 · kind: Granted in consideration for services rendered and to be rendered as a member of the Board of Directors. Granted under the registrant's Amended and Restated 2022 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3. F2 · price: Granted in consideration for services rendered and to be rendered as a member of the Board of Directors. Granted under the registrant's Amended and Restated 2022 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3. F3 · derivative.exercise_date: The options vest at the rate of 1/12th of such options ratably on a monthly basis over the following 12 months on the last day of each calendar month (beginning September 30, 2023), subject to the Reporting Person's continued service to the Company on such vesting dates. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.